{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:00:35Z","timestamp":1790996435970,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bioorg.2021.105041","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T11:30:06Z","timestamp":1622460606000},"page":"105041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Dissection of phospholipases A2 reveals multifaceted peptides targeting cancer cells, Leishmania and bacteria"],"prefix":"10.1016","volume":"114","author":[{"given":"Maria S.","family":"Pe\u00f1a-Carrillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar A.","family":"Pinos-Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristobal","family":"Dom\u00ednguez-Borbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Proa\u00f1o-Bola\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo C.","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105041_b0005","article-title":"Hitchhiking with nature: Snake venom peptides to fight cancer and superbugs","volume":"12","author":"P\u00e9rez","year":"2020","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.bioorg.2021.105041_b0010","doi-asserted-by":"crossref","first-page":"35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.bioorg.2021.105041_b0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fphar.2018.00245","article-title":"Editorial: Adverse effects of cancer chemotherapy: Anything new to improve tolerance and reduce sequelae?","volume":"9","author":"Nurgali","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105041_b0020","unstructured":"C. Ventola, The antibiotic resistance crisis: causes and threats., P T J. 40 (2015) 277\u201383. https:\/\/doi.org\/Article."},{"key":"10.1016\/j.bioorg.2021.105041_b0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: A global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog. Glob. Health."},{"key":"10.1016\/j.bioorg.2021.105041_b0030","doi-asserted-by":"crossref","unstructured":"R. Ma, R. Mahadevappa, H. Kwok, Venom-based peptide therapy: insights into anti-cancer mechanism., Oncotarget. 8 (2017) 100908\u2013100930. https:\/\/doi.org\/10.18632\/oncotarget.21740.","DOI":"10.18632\/oncotarget.21740"},{"key":"10.1016\/j.bioorg.2021.105041_b0035","first-page":"3919","article-title":"The antimicrobial peptides and their potential clinical applications","volume":"11","author":"Lei","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bioorg.2021.105041_b0040","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.trecan.2017.07.004","article-title":"Venom peptides: Improving specificity in cancer therapy","volume":"3","author":"Mahadevappa","year":"2017","journal-title":"Trends in Cancer."},{"key":"10.1016\/j.bioorg.2021.105041_b0045","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/ph6121543","article-title":"Antimicrobial peptides","volume":"6","author":"Bahar","year":"2013","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.bioorg.2021.105041_b0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ddr.21456","article-title":"Harnessing snake venom phospholipases A2 to novel approaches for overcoming antibiotic resistance","volume":"80","author":"Almeida","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2021.105041_b0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/1097-0282(2000)55:1<4::AID-BIP30>3.0.CO;2-M","article-title":"Amphipathic, \u03b1-helical antimicrobial peptides","volume":"55","author":"Tossi","year":"2000","journal-title":"Biopolym. - Pept. Sci. Sect."},{"key":"10.1016\/j.bioorg.2021.105041_b0060","doi-asserted-by":"crossref","unstructured":"B. Lomonte, Y. Angulo, E. Moreno, Synthetic peptides derived from the C-terminal region of Lys49 phospholipase A2 homologues from viperidae snake venoms: biomimetic activities and potential applications., Curr. Pharm. Des. 16 (2010) 3224\u201330. https:\/\/doi.org\/BSP\/CPD\/E-Pub\/000186 [pii].","DOI":"10.2174\/138161210793292456"},{"key":"10.1016\/j.bioorg.2021.105041_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103038","article-title":"Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens","volume":"90","author":"Pedron","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105041_b0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.plipres.2011.12.005","article-title":"Role of lipids in the interaction of antimicrobial peptides with membranes","volume":"51","author":"Teixeira","year":"2012","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bioorg.2021.105041_b0075","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2217\/fmb.12.85","article-title":"Modes of action of Leishmanicidal antimicrobial peptides","volume":"7","author":"Marr","year":"2012","journal-title":"Future Microbiol."},{"key":"10.1016\/j.bioorg.2021.105041_b0080","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/AAC.43.6.1317","article-title":"Peptide antibiotics","volume":"43","author":"Hancock","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2021.105041_b0085","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.3390\/molecules22112037","article-title":"Large-scale analysis of antimicrobial activities in relation to amphipathicity and charge reveals novel characterization of antimicrobial peptides","volume":"22","author":"Wang","year":"2017","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2021.105041_b0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.toxicon.2016.08.007","article-title":"CoaTx-II, a new dimeric Lys49 phospholipase A2 from Crotalus oreganus abyssus snake venom with bactericidal potential: Insights into its structure and biological roles","volume":"120","author":"Almeida","year":"2016","journal-title":"Toxicon."},{"key":"10.1016\/j.bioorg.2021.105041_b0095","doi-asserted-by":"crossref","unstructured":"B. Dhananjaya, P.R. Sivashankari, Snake venom derived molecules in tumor angiogenesis and its application in cancer therapy; an overview, Curr Top Med Chem. 15 (2015) 649\u2013657. https:\/\/doi.org\/CTMC-EPUB-65438 [pii].","DOI":"10.2174\/1568026615666150225113402"},{"key":"10.1016\/j.bioorg.2021.105041_b0100","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.toxicon.2008.03.030","article-title":"Biological and biochemical characterization of new basic phospholipase A2 BmTX-I isolated from Bothrops moojeni snake venom","volume":"51","author":"Calgarotto","year":"2008","journal-title":"Toxicon."},{"key":"10.1016\/j.bioorg.2021.105041_b0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.toxicon.2008.10.021","article-title":"Enzymatic and structural characterization of new PLA2 isoform isolated from white venom of Crotalus durissus ruruima","volume":"53","author":"Diz","year":"2009","journal-title":"Toxicon."},{"key":"10.1016\/j.bioorg.2021.105041_b0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10930-010-9229-5","article-title":"Neurotoxic, myotoxic and cytolytic activities of the new basic PLA2 isoforms BmjeTX-I and BmjeTX-II isolated from the Bothrops marajoensis (Maraj\u00f3 Lancehead) snake venom","volume":"29","author":"Ponce","year":"2010","journal-title":"Protein J."},{"key":"10.1016\/j.bioorg.2021.105041_b0115","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2174\/092986609788923356","article-title":"The phospholipase A2 homologues of snake venoms: Biological activities and their possible adaptive roles","volume":"16","author":"Lomonte","year":"2009","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bioorg.2021.105041_b0120","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.peptides.2008.05.021","article-title":"Myotoxic phospholipases A2 isolated from Bothrops brazili snake venom and synthetic peptides derived from their C-terminal region: Cytotoxic effect on microorganism and tumor cells","volume":"29","author":"Costa","year":"2008","journal-title":"Peptides."},{"key":"10.1016\/j.bioorg.2021.105041_b0125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cellbi.2006.11.007","article-title":"Antitumor effects of cationic synthetic peptides derived from Lys49 phospholipase A2 homologues of snake venoms","volume":"31","author":"Araya","year":"2007","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bioorg.2021.105041_b0130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.biologicals.2009.01.010","article-title":"Antitumor effects of snake venom chemically modified Lys49 phospholipase A2-like BthTX-I and a synthetic peptide derived from its C-terminal region","volume":"37","author":"Gebrim","year":"2009","journal-title":"Biologicals."},{"key":"10.1016\/j.bioorg.2021.105041_b0135","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/AAC.49.4.1340-1345.2005","article-title":"Bactericidal and antiendotoxic properties of short cationic peptides derived from a snake venom Lys49 phospholipase A2","volume":"49","author":"Santamar\u00eda","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2021.105041_b0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejmech.2018.02.055","article-title":"A novel synthetic peptide inspired on Lys49 phospholipase A2 from Crotalus oreganus abyssus snake venom active against multidrug-resistant clinical isolates","volume":"149","author":"Almeida","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105041_b0145","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/molecules26020430","article-title":"A global review on short peptides: Frontiers and perspectives","volume":"26","author":"Apostolopoulos","year":"2021","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2021.105041_b0150","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1039\/D0BM00801J","article-title":"Role and modulation of the secondary structure of antimicrobial peptides to improve selectivity","volume":"8","author":"Liang","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioorg.2021.105041_b0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/BJ20040125","article-title":"Molecular evolution and structure\u2013function relationships of crotoxin-like and asparagine-6-containing phospholipases A2 in pit viper venoms","volume":"381","author":"Chen","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2021.105041_b0160","doi-asserted-by":"crossref","unstructured":"C. Proa\u00f1o-Bola\u00f1os, A. Blasco-Z\u00fa\u00f1iga, J. Almeida, L. Wang, M. Llumiquinga, M. Rivera, M. Zhou, Ti. Chen, C. Shaw. Unravelling the skin secretion peptides of the gliding leaf grog, Agalychnis spurrelli (Hylidae). Biomolecules 2019, 9, 667. https:\/\/doi.org\/10.3390\/biom9110667.","DOI":"10.3390\/biom9110667"},{"key":"10.1016\/j.bioorg.2021.105041_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125221","article-title":"Identification of the lipodepsipeptide MDN-0066, a novel inhibitor of VHL\/HIF pathway produced by a new pseudomonas species","volume":"10","author":"Cautain","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.bioorg.2021.105041_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpc.2019.108612","article-title":"Potential use of 13-mer peptides based on phospholipase and oligoarginine as leishmanicidal agents","volume":"226","author":"Mendes","year":"2019","journal-title":"Comp. Biochem. Physiol. Part C Toxicol. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105041_b0175","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1128\/IAI.00687-13","article-title":"Heme uptake mediated by lhr1 is essential for Leishmania amazonensis virulence","volume":"81","author":"Miguel","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bioorg.2021.105041_b0180","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1021\/acs.jnatprod.7b00876","article-title":"Isolation, derivative synthesis, and structure-activity relationships of antiparasitic bromopyrrole alkaloids from the marine sponge Tedania brasiliensis","volume":"81","author":"Parra","year":"2018","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2021.105041_b0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0041-0101(03)00149-1","article-title":"Comparative study of synthetic peptides corresponding to region 115\u2013129 in Lys49 myotoxic phospholipases A2 from snake venoms","volume":"42","author":"Lomonte","year":"2003","journal-title":"Toxicon."},{"key":"10.1016\/j.bioorg.2021.105041_b0190","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/bcpt.12921","article-title":"Identification of the molecular determinants of the antibacterial activity of LmutTX, a Lys49 phospholipase A2 homologue isolated from Lachesis muta muta Snake Venom (Linnaeus, 1766)","volume":"122","author":"Diniz","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.bioorg.2021.105041_b0195","doi-asserted-by":"crossref","unstructured":"L. Paramo, B. Lomonte, J. Pizarro, J. Bengoechea, J. Gorvel, E. Moreno, Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A2 from Bothrops asper snake venom . Synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region, Eur. J. Biochem. 253 (1998) 452\u2013461. https:\/\/doi.org\/10.1046\/j.1432-1327.1998.2530452.x.","DOI":"10.1046\/j.1432-1327.1998.2530452.x"},{"key":"10.1016\/j.bioorg.2021.105041_b0200","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.toxicon.2004.09.012","article-title":"Antimicrobial activity of myotoxic phospholipases A2 from crotalid snake venoms and synthetic peptide variants derived from their C-terminal region","volume":"45","author":"Santamar\u00eda","year":"2005","journal-title":"Toxicon."},{"key":"10.1016\/j.bioorg.2021.105041_b0205","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.toxicon.2015.07.004","article-title":"Synthesis and characterization of an antibacterial and non-toxic dimeric peptide derived from the C-terminal region of Bothropstoxin-I","volume":"103","author":"Santos","year":"2015","journal-title":"Toxicon."},{"key":"10.1016\/j.bioorg.2021.105041_b0210","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3892\/ijo.2020.5099","article-title":"Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review)","volume":"57","author":"Chiangjong","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bioorg.2021.105041_b0215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s41048-018-0080-0","article-title":"Detection of cancer cells based on glycolytic-regulated surface electrical charges","volume":"5","author":"Le","year":"2019","journal-title":"Biophys. Reports."},{"key":"10.1016\/j.bioorg.2021.105041_b0220","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbamem.2007.11.008","article-title":"Studies on anticancer activities of antimicrobial peptides","volume":"1778","author":"Hoskin","year":"2008","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"10.1016\/j.bioorg.2021.105041_b0225","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/1535-7163.MCT-10-0811","article-title":"Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework","volume":"10","author":"Huang","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2021.105041_b0230","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41598-020-80540-6","article-title":"Fetal bovine serum albumin inhibits antimicrobial peptide activity and binds drug only in complex with \u03b11-antitrypsin","volume":"11","author":"Tang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2021.105041_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/565287","article-title":"Synergistic effects of secretory phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus with cancer chemotherapeutic agents","volume":"2013","author":"Nelson","year":"2013","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bioorg.2021.105041_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103440","article-title":"Fabrication of nanoparticles from a synthesized peptide amphiphile as a versatile therapeutic cargo for high antiproliferative activity in tumor cells","volume":"94","author":"Das","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105041_b0245","first-page":"2231","article-title":"Biophysics in cancer: The relevance of drug-membrane interaction studies","volume":"2016","author":"Alves","year":"1858","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"10.1016\/j.bioorg.2021.105041_b0250","doi-asserted-by":"crossref","first-page":"15392","DOI":"10.3390\/molecules200815392","article-title":"The potential use of natural and structural analogues of antimicrobial peptides in the fight against neglected tropical diseases","volume":"20","author":"Ang\u00e9lique","year":"2015","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2021.105041_b0255","unstructured":"A. Silveira, S. Oshiro, S. Nicholls, L. Buzanovsky, Leishmaniasis - Epidemiological Report of the Americas, 2019. www.paho.org (accessed March 1, 2021)."},{"key":"10.1016\/j.bioorg.2021.105041_b0260","article-title":"Drug resistance and treatment failure in leishmaniasis: A 21st century challenge","volume":"11","author":"Ponte","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2021.105041_b0265","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1074\/jbc.M410795200","article-title":"Temporins, small antimicrobial peptides with leishmanicidal activity","volume":"280","author":"Mangoni","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2021.105041_b0270","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1042\/bj3300453","article-title":"The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1\u20138)M(1\u201318), a synthetic cecropin A-melittin hybrid peptide","volume":"330","author":"D\u00edaz","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2021.105041_b0275","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.exppara.2007.07.011","article-title":"Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals","volume":"118","author":"L\u00f6fgren","year":"2008","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bioorg.2021.105041_b0280","unstructured":"S. Cobb, P. Denny, Antimicrobial peptides for leishmaniasis., Curr. Opin. Investig. Drugs, 2010, Vol.11(8), Pp.868-875 [Peer Rev. Journal]. (2010). https:\/\/www.ncbi.nlm.nih.gov\/labs\/articles\/20721829\/ (accessed March 1, 2021)."},{"key":"10.1016\/j.bioorg.2021.105041_b0285","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/AAC.02328-15","article-title":"Identification of synthetic and natural host defense peptides with leishmanicidal activity","volume":"60","author":"Marr","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2021.105041_b0290","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.3390\/ijms22094400","article-title":"Peptides to tackle leishmaniasis: Current status and future directions","volume":"22","author":"Robles","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2021.105041_b0295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/femspd\/ftaa053","article-title":"Cruzioseptins, antibacterial peptides from Cruziohyla calcarifer skin, as promising leishmanicidal agents","volume":"78","author":"Mendes","year":"2020","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.bioorg.2021.105041_b0300","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.peptides.2011.01.011","article-title":"Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells","volume":"32","author":"P\u00e9rez","year":"2011","journal-title":"Peptides."},{"key":"10.1016\/j.bioorg.2021.105041_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119286","article-title":"Targeted delivery of antimicrobial peptide by Cry protein crystal to treat intramacrophage infection","volume":"217","author":"Yang","year":"2019","journal-title":"Biomaterials."},{"key":"10.1016\/j.bioorg.2021.105041_b0310","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cellimm.2016.10.001","article-title":"Mammalian host defense peptides and their implication on combating Leishmania infection","volume":"309","author":"Abdossamadi","year":"2016","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.bioorg.2021.105041_b0315","doi-asserted-by":"crossref","unstructured":"S. K\u00fcckelhaus, D. de Aquino, T. Borges, D. Moreira, L. de M. Leite, M. Muniz, C. K\u00fcckelhaus, G. Sierra, M. Prates, C. Bloch, J. Leite, Phylloseptin-1 is leishmanicidal for amastigotes of Leishmania amazonensis inside infected macrophages, Int. J. Environ. Res. Public Health. 17 (2020) 1\u201314. https:\/\/doi.org\/10.3390\/ijerph17134856.","DOI":"10.3390\/ijerph17134856"},{"key":"10.1016\/j.bioorg.2021.105041_b0320","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1128\/IAI.70.8.4638-4642.2002","article-title":"Expression of inducible nitric oxide synthase in skin lesions of patients with American cutaneous Leishmaniasis","volume":"70","author":"Qadoumi","year":"2002","journal-title":"Infect. Immun."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821004181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821004181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:20:01Z","timestamp":1758615601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821004181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":64,"alternative-id":["S0045206821004181"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105041","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dissection of phospholipases A2 reveals multifaceted peptides targeting cancer cells, Leishmania and bacteria","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105041"}}